Vor Ort
Merkzettel Warenkorb
Produktbild: Aspartic Acid Proteases as Therapeutic Targets
Band 45 - 12%

Aspartic Acid Proteases as Therapeutic Targets Aspartic Acid Proteases

Aus der Reihe Methods and Principles in Medicinal Chemistry
12% sparen

194,99 € UVP 222,00 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

25.08.2010

Abbildungen

schwarz-weiss Illustrationen, farbige Illustrationen, Tabellen, schwarz-weiss

Herausgeber

Arun K. Ghosh

Verlag

Wiley-VCH

Seitenzahl

640

Maße (L/B/H)

24,8/17,7/3,8 cm

Gewicht

1324 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-3-527-31811-7

Beschreibung

Rezension

"Overall, this book comprises an excellent themes and publications based on aspartic protease research, and I strongly recommend this book for novices, as well as experienced researchers in this area." (ChemMedChem, 2011)

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

25.08.2010

Abbildungen

schwarz-weiss Illustrationen, farbige Illustrationen, Tabellen, schwarz-weiss

Herausgeber

Arun K. Ghosh

Verlag

Wiley-VCH

Seitenzahl

640

Maße (L/B/H)

24,8/17,7/3,8 cm

Gewicht

1324 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-3-527-31811-7

Herstelleradresse

Wiley-VCH GmbH
product_safety@wiley.com
Wiley-VCH GmbH, Boschstrasse 12, DE-69469 Weinheim

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
Die Leseprobe wird geladen.
  • Produktbild: Aspartic Acid Proteases as Therapeutic Targets
  • OVERVIEW OF ASPARTIC ACID PROTEASES
    Introduction to the Aspartic Proteases Family
    Aspartic Acid Proteases, Structure, Function and Inhibition
    Human Aspartic Proteinases
    Structure-based Drug Design Strategies for the Inhibition of Aspartic Acid Proteases

    HIV-1 PROTEASE FOR THE TREATMENT OF HIV/AIDS
    HIV-1 Protease: Role in Viral Replication, Protein-Ligand X-ray Crystal Structures and Inhibitor Design
    First generation FDA Approved HIV protease inhibitors
    Second-Generation Approved HIV Protease Inhibitors for Treatment of HIV/AIDS
    Design, Conception and Clinical Development of Darunavir, a HIV-1 Protease Inhibitor to Combat Drug Resistance
    Development of Protease Inhibitors and Challenges to Drug-Resistance of HIV-1

    RENIN FOR TREATMENT OF HYPERTENSION
    Discovery and Development of Aliskiren, the First-in-Class Direct Renin Inhibitor for the Treatment of Hypertension
    Evolution of Diverse Classes of Renin Inhibitors Through the Years

    GAMMA-SECRETASE FOR TREATMENT OF ALZHEIMER'S DISEASE
    Chemistry and Biology of gamma-Secretase as a Possible Target for Alzheimer's Disease
    Gamma-Secretase Inhibition: An overview of Development of Inhibitors for Alzheimer's Disease

    BETA-SECRETASE FOR TREATMENT OF ALZHEIMER'S DISEASE
    BACE - An (Almost) Perfect Target for Staving Off Alzheimer's Disease
    Discovery of Memapsin 2 (BACE1), Design of Inhibitors and Drug-design Tools
    Peptidomimetic BACE1 Inhibitors for Treatment of Alzheimer's Disease: Design and Evolution
    Non-Peptide BACE1 Inhibitors: Design and Synthesis

    PLASMEPSINS AND OTHER ASPARTIC PROTEASES AS DRUG TARGETS
    The Plasmepsin Family as Antimalarial Drug Targets
    Design and Synthesis of Plasmepsin Inhibitors for Treatment of Malaria
    Fungal aspartic proteases as possible therapeutic targets